A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Abstract

Background: Infection with hepatitis C poses a global health problem that affects 200 million chronically infected patients globally. Infected patients with hepatitis C virus (HCV) run a high risk of developing fibrosis, cirrhosis and hepatocellular carcinoma. Aim of work: to evaluate the occurrence of hepatocellular carcinoma (HCC) in DAA-treated patients with chronic hepatitis C (CHC). Patient and Methods: The research involved 500 DAAS-treated patients who had chronic viral hepatitis C. We carried out this retrospective study at